Ignite Creation Date:
2025-12-18 @ 8:11 AM
Ignite Modification Date:
2025-12-23 @ 10:37 PM
Study NCT ID:
NCT05014724
Status:
None
Last Update Posted:
2024-01-25 00:00:00
First Post:
2021-08-19 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
CIDP07 Rozanolixizumab Post Trial Access Program (the PTA)
Sponsor:
Organization:
Raw JSON
{}